Elacridar-d4 (Major)
Gecertificeerd

Elacridar-d4 (Major)

Catalog #: HY-W777317-01
Maat: 1 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

Description

Elacridar-d4 (Major) is the deuterium labeled Elacridar. Elacridar is an orally active P-glycoprotein (Pgp) and breast cancer resistance protein (BCRP) inhibitor. Elacridar can be used to examine the influence of efflux transporters on agent distribution to brain and the research of cancer[1][2].

CAS Number

1189481-51-3

UNSPSC

12352005

Target

BCRP; Isotope-Labeled Compounds; P-glycoprotein

Related Pathways

Membrane Transporter/Ion Channel; Others

Applications

Cancer-programmed cell death

Field of Research

Cancer

Smiles

O=C(NC1=CC=C(C([2H])(C([2H])(N2CCC(C=C(C(OC)=C3)OC)=C3C2)[2H])[2H])C=C1)C4=CC=CC5=C4NC6=C(C5=O)C=CC=C6OC

Molecular Formula

C34H29D4N3O5

Molecular Weight

567.67

Shipping Conditions

Room temperature

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-W777317/

Scientific Category

Isotope-Labeled Compounds

Clinical Information

No Development Reported

Beschrijving

Elacridar-d4 (Major) is the deuterium labeled Elacridar. Elacridar is an orally active P-glycoprotein (Pgp) and breast cancer resistance protein (BCRP) inhibito

Specificaties

ProductnaamElacridar-d4 (Major)
Categorie
Beschikbare grootte1 mg
CatalogusnummerHY-W777317-01